These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2707854)

  • 1. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.
    Briles DE; Forman C; Horowitz JC; Volanakis JE; Benjamin WH; McDaniel LS; Eldridge J; Brooks J
    Infect Immun; 1989 May; 57(5):1457-64. PubMed ID: 2707854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis.
    Waltman WD; Gray B; McDaniel LS; Briles DE
    J Clin Microbiol; 1988 Sep; 26(9):1635-40. PubMed ID: 2460493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid.
    McDaniel LS; Waltman WD; Gray B; Briles DE
    Microb Pathog; 1987 Oct; 3(4):249-60. PubMed ID: 2462151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.
    Mold C; Rodic-Polic B; Du Clos TW
    J Immunol; 2002 Jun; 168(12):6375-81. PubMed ID: 12055255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against pneumococcal C-polysaccharide are not protective.
    Nielsen SV; Sørensen UB; Henrichsen J
    Microb Pathog; 1993 Apr; 14(4):299-305. PubMed ID: 8326853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages.
    Fabrizio K; Manix C; Tian H; van Rooijen N; Pirofski LA
    Vaccine; 2010 Nov; 28(47):7542-50. PubMed ID: 20800700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides.
    Chudwin DS; Artrip SG; Schiffman G
    Clin Immunol Immunopathol; 1987 Jul; 44(1):114-21. PubMed ID: 3297436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.
    McDaniel LS; Scott G; Kearney JF; Briles DE
    J Exp Med; 1984 Aug; 160(2):386-97. PubMed ID: 6381634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides.
    Usinger WR; Lucas AH
    Infect Immun; 1999 May; 67(5):2366-70. PubMed ID: 10225896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
    Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
    Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.
    McDaniel LS; Sheffield JS; Delucchi P; Briles DE
    Infect Immun; 1991 Jan; 59(1):222-8. PubMed ID: 1987036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.
    Sun Y; Hwang Yi; Nahm MH
    Infect Immun; 2001 Jan; 69(1):336-44. PubMed ID: 11119522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide.
    Burns T; Zhong Z; Steinitz M; Pirofski LA
    Infect Immun; 2003 Dec; 71(12):6775-83. PubMed ID: 14638763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.
    McDaniel LS; Benjamin WH; Forman C; Briles DE
    J Immunol; 1984 Dec; 133(6):3308-12. PubMed ID: 6491288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.
    Fabrizio K; Manix C; Guimaraes AJ; Nosanchuk JD; Pirofski LA
    Clin Vaccine Immunol; 2010 May; 17(5):713-21. PubMed ID: 20200186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.